136 related articles for article (PubMed ID: 31858433)
1. Transoral robotic surgery for squamous cell carcinoma of the oropharynx in a primarily human papillomavirus-negative patient population.
Viros Porcuna D; Pollan Guisasola C; Viña Soria C; Cirauqui Cirauqui B; Pardo Muñoz L; Collurá F; Mesia Nin R
Clin Transl Oncol; 2020 Aug; 22(8):1303-1311. PubMed ID: 31858433
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma with low rates of adjuvant therapy: A consecutive single-institution study from 2013 to 2020.
Meldgaard Justesen M; Kronberg Jakobsen K; Fenger Carlander AL; Hjordt Holm Larsen M; Wessel I; Kiss K; Friborg J; Ibrahim Channir H; Rubek N; Grønhøj C; von Buchwald C
Oral Oncol; 2024 May; 152():106783. PubMed ID: 38569317
[TBL] [Abstract][Full Text] [Related]
3. Oncological outcomes post transoral robotic surgery (TORS) for HPV-associated oropharyngeal squamous cell carcinoma, a single-centre retrospective Australian study.
Kornfeld B; Taha A; Kyang L; Sim HW; Dewhurst S; McCloy R; Chin V; Earls P; Parker A; Leavers B; Forstner D; Floros P; Crawford J; Gallagher R
J Robot Surg; 2024 May; 18(1):226. PubMed ID: 38806847
[TBL] [Abstract][Full Text] [Related]
4. Survival and Swallowing Function after Primary Radiotherapy versus Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
Hughes RT; Levine BJ; May N; Shenker RF; Yang JH; Lanier CM; Frizzell BA; Greven KM; Waltonen JD
ORL J Otorhinolaryngol Relat Spec; 2023; 85(5):284-293. PubMed ID: 37647863
[TBL] [Abstract][Full Text] [Related]
5. Quality of Life After Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharynx Cancer.
Silver JA; Bouganim N; Richardson K; Henry M; Mascarella MA; Ramirez-GarciaLuna J; Golabi N; Mlynarek AM; Zeitouni A; Hier MP; Caglar D; Esfahani K; Sadeghi N
JAMA Otolaryngol Head Neck Surg; 2024 Jan; 150(1):65-74. PubMed ID: 38060238
[TBL] [Abstract][Full Text] [Related]
6. Differences in Functional and Survival Outcomes Between Patients Receiving Primary Surgery vs Chemoradiation Therapy for Treatment of T1-T2 Oropharyngeal Squamous Cell Carcinoma.
Amin DR; Philips R; Bertoni DG; Mastrolonardo EV; Campbell DJ; Agarwal AM; Tekumalla S; Urdang ZD; Luginbuhl AJ; Cognetti DM; Curry JM
JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):980-986. PubMed ID: 37422846
[TBL] [Abstract][Full Text] [Related]
7. Comparison of margins and survival between transoral robotic surgery (TORS) and non-robotic endoscopic surgery for oropharyngeal cancer.
Groysman M; Gleadhill C; Baker A; Wang SJ; Bearelly S
Am J Otolaryngol; 2023; 44(6):103982. PubMed ID: 37531886
[TBL] [Abstract][Full Text] [Related]
8. [Preliminary outcomes of neoadjuvant chemoimmunotherapy combined with transoral robotic surgery for locally advanced oropharyngeal squamous cell carcinoma].
Chen RH; Liang FY; Han P; Lin PL; Lin XJ; Wang JY; Kong XW; Huang XM
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Apr; 59(4):329-334. PubMed ID: 38599642
[No Abstract] [Full Text] [Related]
9. De-Escalated Adjuvant Therapy After Transoral Robotic Surgery for Human Papillomavirus-Related Oropharyngeal Carcinoma: The Sinai Robotic Surgery (SIRS) Trial.
Miles BA; Posner MR; Gupta V; Teng MS; Bakst RL; Yao M; Misiukiewicz KJ; Chai RL; Sharma S; Westra WH; Kim-Schulze S; Dayal B; Sobotka S; Sikora AG; Som PM; Genden EM
Oncologist; 2021 Jun; 26(6):504-513. PubMed ID: 33675133
[TBL] [Abstract][Full Text] [Related]
10. Salvage transoral robotic surgery in recurrent oropharyngeal carcinoma: a single-center retrospective study.
Ansarin M; Pietrobon G; Tagliabue M; Mossinelli C; Ruju F; Maffini F; Rocca MC; Alterio D; Simon C; Zorzi SF
Eur Arch Otorhinolaryngol; 2024 Jun; 281(6):3167-3177. PubMed ID: 38546850
[TBL] [Abstract][Full Text] [Related]
11. Preoperative Circulating Tumor HPV DNA and Oropharyngeal Squamous Cell Disease.
Lam D; Sangal NR; Aggarwal A; Rajasekaran K; Cannady SB; Basu D; Chalian A; Weinstein G; Brody RM
JAMA Otolaryngol Head Neck Surg; 2024 May; 150(5):444-450. PubMed ID: 38573644
[TBL] [Abstract][Full Text] [Related]
12. Staged neck dissection prior to transoral robotic surgery for oropharyngeal cancer: does it reduce post-operative complication rates? A multi-centre study of 104 patients.
Blom M; Zhang H; Tescher A; Dixon B; Magarey M
Eur Arch Otorhinolaryngol; 2023 Nov; 280(11):5067-5072. PubMed ID: 37561189
[TBL] [Abstract][Full Text] [Related]
13. Neo-adjuvant chemotherapy and transoral robotic surgery in locoregionally advanced oropharyngeal cancer.
Costantino A; Sampieri C; De Virgilio A; Kim SH
Eur J Surg Oncol; 2023 Dec; 49(12):107121. PubMed ID: 37879162
[TBL] [Abstract][Full Text] [Related]
14. Functional Outcomes in Patients with Human Papillomavirus-Associated Oropharyngeal Squamous Cell Cancer Treated with Trimodality Therapy.
Lu JS; Cao AC; Shimunov D; Sun L; Lukens JN; Lin A; Cohen RB; Basu D; Cannady SB; Rajasekaran K; Weinstein GS; Brody RM
Laryngoscope; 2023 Nov; 133(11):3013-3020. PubMed ID: 37129315
[TBL] [Abstract][Full Text] [Related]
15. Positive Deep Initial Incision Margin Affects Outcomes in TORS for HPV+ Oropharynx Cancer.
Kejner A; Gentile C; Porterfield Z; Carroll WR; Buczek EP
Laryngoscope; 2023 May; 133(5):1132-1137. PubMed ID: 35809041
[TBL] [Abstract][Full Text] [Related]
16. Transoral robotic surgery for the benefit of patients with head and neck cancer of unknown primary: our experience at St George's University Hospital, London.
Mistry R; Walker A; Kim D; Ofo E
Ann R Coll Surg Engl; 2020 Jul; 102(6):442-450. PubMed ID: 32347742
[TBL] [Abstract][Full Text] [Related]
17. Characterizing postoperative physiologic swallow function following transoral robotic surgery for early stage tonsil, base of tongue, and unknown primary human papillomavirus-associated squamous cell carcinoma.
Ottenstein L; Cornett H; Switchenko JM; Nathan M; Thomas S; Gillespie AI; McColloch N; Barrett T; Studer MB; Brinkman M; Kaka AS; Boyce BJ; Ferris RL; Aiken AH; El-Deiry M; Beitler JJ; Patel MR
Head Neck; 2021 May; 43(5):1629-1640. PubMed ID: 33547716
[TBL] [Abstract][Full Text] [Related]
18. Neck scar perception after neck dissection in HPV-associated oropharyngeal squamous cell carcinoma.
Au VH; Miller LE; Mitchell MB; Larson AR; Lin DT; Feng AL; Richmon JD
Am J Otolaryngol; 2024; 45(1):104074. PubMed ID: 37865986
[TBL] [Abstract][Full Text] [Related]
19. Trans oral robotic surgery for oropharyngeal cancer: A multi institutional experience.
De Virgilio A; Pellini R; Cammaroto G; Sgarzani R; De Vito A; Gessaroli M; Costantino A; Petruzzi G; Festa BM; Campo F; Moretti C; Pichi B; Mercante G; Spriano G; Vicini C; Meccariello G
Eur J Surg Oncol; 2023 Sep; 49(9):106945. PubMed ID: 37331862
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Hospital Safety-Net Burden Status on Patients with HPV-Positive Oropharyngeal Cancer.
Gilja S; Kumar A; Kapustin D; Su V; Rubin SJ; Chai R; Roof SA; Khan MN
Laryngoscope; 2024 Apr; 134(4):1733-1740. PubMed ID: 37933810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
